These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 24905005)

  • 21. The role of epigenetic regulation in stem cell and cancer biology.
    van Vlerken LE; Hurt EM; Hollingsworth RE
    J Mol Med (Berl); 2012 Jul; 90(7):791-801. PubMed ID: 22660276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evolving cancer stem cell paradigm: implications in veterinary oncology.
    Pang LY; Argyle DJ
    Vet J; 2015 Aug; 205(2):154-60. PubMed ID: 25634078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The multi-factorial nature of clinical multidrug resistance in cancer.
    Assaraf YG; Brozovic A; Gonçalves AC; Jurkovicova D; Linē A; Machuqueiro M; Saponara S; Sarmento-Ribeiro AB; Xavier CPR; Vasconcelos MH
    Drug Resist Updat; 2019 Sep; 46():100645. PubMed ID: 31585396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance.
    Bhat GR; Sethi I; Sadida HQ; Rah B; Mir R; Algehainy N; Albalawi IA; Masoodi T; Subbaraj GK; Jamal F; Singh M; Kumar R; Macha MA; Uddin S; Akil ASA; Haris M; Bhat AA
    Cancer Metastasis Rev; 2024 Mar; 43(1):197-228. PubMed ID: 38329598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-renewal of tumor cells: epigenetic determinants of the cancer stem cell phenotype.
    Ravasio R; Ceccacci E; Minucci S
    Curr Opin Genet Dev; 2016 Feb; 36():92-9. PubMed ID: 27153353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
    Biswas A; De S
    Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The crossroads between cancer stem cells and aging.
    Santos Franco S; Raveh-Amit H; Kobolák J; Alqahtani MH; Mobasheri A; Dinnyes A
    BMC Cancer; 2015; 15 Suppl 1(Suppl 1):S1. PubMed ID: 25708542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance.
    Roy Burman D; Das S; Das C; Bhattacharya R
    Mol Biol Rep; 2021 Jan; 48(1):897-914. PubMed ID: 33400075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic regulation of cancer stem cell gene expression.
    Bapat SA
    Subcell Biochem; 2013; 61():419-34. PubMed ID: 23150261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic regulation of cancer stem cells and clinical challenges.
    Ni C; Huang J
    Clin Transl Oncol; 2013 Apr; 15(4):253-8. PubMed ID: 22926945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance.
    Honoki K; Fujii H; Kubo A; Kido A; Mori T; Tanaka Y; Tsujiuchi T
    Oncol Rep; 2010 Aug; 24(2):501-5. PubMed ID: 20596639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using Epigenetic Therapy to Overcome Chemotherapy Resistance.
    Strauss J; Figg WD
    Anticancer Res; 2016 Jan; 36(1):1-4. PubMed ID: 26722021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers of Bad Biology: Curse or a Blessing?
    Banerjee S; Sicklick JK
    Ann Surg Oncol; 2019 Feb; 26(2):318-320. PubMed ID: 30539488
    [No Abstract]   [Full Text] [Related]  

  • 34. Targeting Epigenetic Modifiers of Tumor Plasticity and Cancer Stem Cell Behavior.
    Kumar VE; Nambiar R; De Souza C; Nguyen A; Chien J; Lam KS
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cancer stem cells as a possible source of tumor initiation and progression].
    Puchinskaya MV
    Vopr Onkol; 2016; 62(1):14-23. PubMed ID: 30444327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polytherapy and Targeted Cancer Drug Resistance.
    Chatterjee N; Bivona TG
    Trends Cancer; 2019 Mar; 5(3):170-182. PubMed ID: 30898264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the specific epigenetic alterations associated with chemo-resistance via reprogramming of cancer cells.
    Kim JJ; Rai R
    Med Hypotheses; 2015 Dec; 85(6):710-4. PubMed ID: 26527497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNAs regulate drug resistance in cancer.
    Liu K; Gao L; Ma X; Huang JJ; Chen J; Zeng L; Ashby CR; Zou C; Chen ZS
    Mol Cancer; 2020 Mar; 19(1):54. PubMed ID: 32164712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic regulation of mRNA mediates the phenotypic plasticity of cancer cells during metastasis and therapeutic resistance (Review).
    Zhang C; Liang S; Zhang H; Wang R; Qiao H
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38131215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy.
    Lu Y; Chan YT; Tan HY; Li S; Wang N; Feng Y
    Mol Cancer; 2020 Apr; 19(1):79. PubMed ID: 32340605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.